A negligence lawsuit filed against Medtronic over a failed Transvene defibrillator lead isn’t preempted by federal law, an Indiana appeals court rules.

Medtronic (NYSE:MDT) can’t use preemption to shake a negligence lawsuit filed over a failed Transvene defibrillator lead, an Indiana appeals court ruled last week.

The Court of Appeals of Indiana denied the Fridley, Minn.-based medical device company’s bid for summary judgment in the case Oct. 11, in which Medtronic argued that federal preemption laws barred the negligence claim against it by the family of David Malander Sr.

Malander received a Medtronic defibrillator and the accompanying Transvene lead in 1997, according to court records. The defibrillator was upgraded in 2004, but the lead was left in place despite 9 episodes of random short V-V intervals, according to the records.